NFKB2 and adult T-cell leukemia/lymphoma: We previously showed that with TAX-transformed F8 cells from a murine model of HTLV-1-induced ATLL that nanoparticle siRNA targeting both p65 and p100/52 in vitro yields additive suppressive effects on malignant cell growth [52].